Article
Single-cell multiomics dissection of basal and antigen-specific activation states of CD19-targeted CAR T cells.
Journal for immunotherapy of cancer - 1 May 2021
Bai Zhiliang, Lundh Stefan, Kim Dongjoo, Woodhouse Steven, Barrett David M, Myers Regina M, Grupp Stephan A, Maus Marcela V, June Carl H, Camara Pablo G, Melenhorst J Joseph, Fan Rong
Abstract excerpt
BACKGROUND: Autologous T cells engineered to express a chimeric antigen receptor (CAR) specific for CD19 molecule have transformed the therapeutic landscape in patients with highly refractory leukemia and lymphoma, and the use of donor-generated allogeneic CAR T is paving the way for further breakthroughs in the treatment of cancer. However, it remains unknown how the intrinsic heterogeneities of these engineered...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
